Stuttering frequency (% SS) · children aged six years and younger who stutter
1 finding from 1 review
Stuttering severity · children aged six years and younger who stutter
1 finding from 1 review
Impact of interventions for stuttering on emotional, cognitive and psychosocial domains, or quality of life · children aged six years and younger who stutter
1 finding from 1 review
Adverse events during treatment · adults and children with cystic fibrosis
The review found no eligible studies for this question.
2 findings from 1 review
Cerebral palsy ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Significant mental developmental delay ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Legal blindness ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurodevelopmental impairment (composite outcome) ‐ not measured · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal seizures ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hearing loss · Children with otitis media with effusion
Summary of findings: oral steroids plus antibiotic showed no clear difference in hearing loss [2 months]1 compared with control plus antibiotic (moderate certainty).
1 finding from 1 review
All‐cause mortality: Structured telephone support versus usual care · patients with heart failure
Summary of findings ‐ structured telephone support or telemonitoring probably leads to lower all‐cause mortality: Structured telephone support versus usual care compared with usual care ‐ all‐cause mortality (moderate certainty).
1 finding from 1 review
Reoperation · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR FUSION showed no clear difference in reoperations Number of patients requiring a revision surgery compared with INTERSPINOUS SPACERS (high certainty).
1 finding from 1 review
Hearing loss · Children with otitis media with effusion
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People undergoing radiotherapy for uterine cervical cancer
1 finding from 1 review
no estimate extracted
2 participants
GRADE not reported
Acute and late GI toxicity (grade 2+) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Sucralfate showed no clear difference in acute and late GI toxicity (grade 2+) [acute = during RT; late = 6… compared with placebo (moderate certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People undergoing pelvic radiotherapy for urological, gynaecological or colorectal cancer
Summary of findings: Sucralfate may leads to lower diarrhoea (grade 2+) [during RT] compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea (grade 2+) · People with urological, gynaecological or colorectal cancer
It is very uncertain whether summary of findings: Amifostine changes diarrhoea (grade 2+) during treatment compared with no intervention (very low certainty).
1 finding from 1 review
Death during the study · adults and children with sickle cell disease and an increased risk of stroke
1 finding from 1 review
Death during the study · people with sickle cell disease
1 finding from 1 review
All‐cause mortality · people with sickle cell disease
Summary of findings ‐ Hydroxyurea showed no clear difference in death during the study (all deaths) compared with placebo (moderate certainty).